Basic Information
ID: ALA5250573
Type: Functional
Description: Antiviral activity against SARS-CoV-2 strain BetaCov/Belgium/GHB-03021/2020 infected in African Vero-E6 tagged with GFP assessed as decrease in cytopathic effect in presence of CP100356 at 2 uM measured after 72 hrs
Organism: Severe acute respiratory syndrome coronavirus 2
Strain: BetaCov/Belgium/GHB-03021/2020
Cell type: Vero E6
Activity Charts
Bioactivity
Activity Types for Assay ALA5250573
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 507.54 | 0.54 | 0.54 |
| 564.64 | 1.74 | 1.74 |
| 552.60 | 1.87 | 1.87 |
| 663.56 | 2.32 | 2.32 |
| 540.64 | 0.88 | 0.88 |
| 633.53 | 2.31 | 2.31 |
| 589.48 | 2.26 | 2.26 |
| 603.50 | 2.30 | 2.30 |
| 534.61 | 1.73 | 1.73 |
| 621.49 | 2.44 | 2.44 |
| 671.50 | 3.32 | 3.32 |